SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shreekrishna Biotech informs about closure of trading window

30 Jan 2017 Evaluate

Shreekrishna Biotech has informed that the meeting of the Board of Directors of the Company will be held on February 13, 2017, to consider the unaudited financial results of the company for quarter and year ending December 31, 2016. As per ‘Code of Internal Procedure and Conduct for Prevention of Insider Trading’ in Shares of the Company (‘Code’), the trading window will remain closed from January 31, 2017 to February 14, 2017 in connection with the announcement of the unaudited financial results of the company for quarter and year ending December 31, 2016 for Directors and other employees of the Company covered under the Code. The trading window will reopen on February 14, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×